Charles Schwab Investment Management Inc. Sells 15,307 Shares of Proto Labs, Inc. $PRLB

Key Points

• Charles Schwab Investment Management Inc. reduced its stake in Proto Labs, Inc. by 5.3%, holding now 274,038 shares, valued at approximately $9.6 million.
• Proto Labs reported $0.41 EPS for the last quarter, surpassing estimates, with a 7.6% increase in revenue year-over-year, totaling $135.06 million.
• Analysts recently upgraded Proto Labs to a "strong-buy" rating, with a consensus price target now set at $52.50.

Charles Schwab Investment Management Inc. decreased its holdings in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) by 5.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 274,038 shares of the industrial products company's stock after selling 15,307 shares during the quarter. Charles Schwab Investment Management Inc. owned about 1.15% of Proto Labs worth $9,602,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in PRLB. GAMMA Investing LLC increased its stake in Proto Labs by 249.4% during the first quarter. GAMMA Investing LLC now owns 926 shares of the industrial products company's stock valued at $32,000 after acquiring an additional 661 shares during the period. Quarry LP increased its position in shares of Proto Labs by 175.7% during the fourth quarter. Quarry LP now owns 1,585 shares of the industrial products company's stock valued at $62,000 after purchasing an additional 1,010 shares during the period. CWM LLC raised its stake in shares of Proto Labs by 50.4% in the first quarter. CWM LLC now owns 1,840 shares of the industrial products company's stock valued at $64,000 after purchasing an additional 617 shares in the last quarter. PNC Financial Services Group Inc. raised its stake in shares of Proto Labs by 14.1% in the first quarter. PNC Financial Services Group Inc. now owns 2,165 shares of the industrial products company's stock valued at $76,000 after purchasing an additional 267 shares in the last quarter. Finally, LPL Financial LLC bought a new position in Proto Labs in the fourth quarter worth $210,000. Institutional investors and hedge funds own 84.54% of the company's stock.

Insider Activity at Proto Labs

In other Proto Labs news, CEO Suresh Krishna bought 1,725 shares of the stock in a transaction dated Monday, August 4th. The stock was bought at an average cost of $43.51 per share, for a total transaction of $75,054.75. Following the completion of the purchase, the chief executive officer owned 18,021 shares in the company, valued at $784,093.71. This represents a 10.59% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.70% of the company's stock.

Proto Labs Stock Performance

Proto Labs stock traded down $1.08 during trading hours on Friday, hitting $49.69. 207,182 shares of the stock were exchanged, compared to its average volume of 211,909. The stock has a market capitalization of $1.19 billion, a P/E ratio of 82.81 and a beta of 1.33. Proto Labs, Inc. has a 12 month low of $26.34 and a 12 month high of $51.09. The business's 50-day moving average is $43.06 and its two-hundred day moving average is $39.49.

Proto Labs (NYSE:PRLB - Get Free Report) last announced its earnings results on Thursday, July 31st. The industrial products company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.33 by $0.08. Proto Labs had a return on equity of 2.22% and a net margin of 2.91%.The business had revenue of $135.06 million for the quarter, compared to the consensus estimate of $128.05 million. During the same period in the previous year, the business earned $0.38 EPS. Proto Labs's revenue was up 7.6% compared to the same quarter last year. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. On average, equities analysts predict that Proto Labs, Inc. will post 0.81 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on PRLB shares. Cantor Fitzgerald boosted their price target on shares of Proto Labs from $50.00 to $51.00 and gave the company an "overweight" rating in a report on Friday, August 1st. Wall Street Zen raised shares of Proto Labs from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 2nd. Finally, Craig Hallum upgraded shares of Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 price target for the company in a research note on Friday, August 1st. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat.com, Proto Labs presently has an average rating of "Moderate Buy" and an average target price of $52.50.

About Proto Labs

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.